Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
STAM antisense RNA 2 is an RNA transcript generated from the region of the genome opposite to the STAM2 gene. Antisense RNAs, like STAM-AS2, act at the RNA level to regulate the expression of their sense partner genes through mechanisms such as hybridization to messenger RNA or recruiting chromatin modifiers. While antisense RNAs are broadly important in controlling gene expression, and have been proposed as research and potential therapeutic tools, there is no evidence that STAM-AS2 itself is a characterized therapeutic target, and little to no disease-specific literature describes its phenotype or utility[5][8].
Antisense RNA molecules regulate target genes by binding complementary mRNA and inhibiting translation, or by modifying chromatin state[4][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on STAM antisense RNA 2 (STAM-AS2).